Pulmonary toxicity and cancer treatment

Hospital Medicine

Volumn 65, Issue 8, 2004, Pages 462-465

  Fennell, Dean A ^a   Rudd, Robin M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; ETOPOSIDE; FLUDARABINE; GAMMA INTERFERON; GEFITINIB; GEMCITABINE; IRINOTECAN; METHOTREXATE; MITOMYCIN; NITROFURANTOIN; PLATINUM; PROCARBAZINE; RALTITREXED; RITUXIMAB; SULFONAMIDE; THALIDOMIDE;

CANCER CHEMOTHERAPY; CELL ACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; COUGHING; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG MECHANISM; DYSPNEA; FATALITY; FEVER; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY REACTION; HYPOXIA; INCIDENCE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG CANCER; LUNG EDEMA; LUNG EMBOLISM; LUNG FIBROSIS; LUNG FUNCTION; LUNG INJURY; LUNG TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; PLEURA EFFUSION; RISK ASSESSMENT; RISK FACTOR;

EID: 4444356834     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2004.65.8.15490     Document Type: Conference Paper

References (27)

1. Behrens RJ, Gulley JL, Dahut WL (2003) Pulmonary toxicity during prostate cancer treatment with docetaxe] and thalidomide. Am J Ther 10: 228-32
2. Boiselle PM, Morrin MM, Huberman MS (2000) Gemcitabine pulmonary toxicity: CT features. J Comput Assist Tomogr 24: 977-80
3. Dalgleish AG, Woods RL, Levi JA (1984) Bleomycin pulmonary toxicity: its relationship to renal dysfunction. Med Pediatr Oncol 12: 313-17
4. Dunsford ML, Mead GM, Bateman AC, Cook T, Tung K (1999) Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Ann Oncol 10: 943-7
5. Giaccone G, Herbst RS, Manegold C et al (2004) Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial - INTACT 1. J Clin Oncol 22: 777-84
6. Helman DL Jr, Byrd JC, Ales NC, Shorr AF (2002) Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest 122: 785-90
7. Herbst RS, Giaccone G, Schiller JH et al (2004) Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 2. J Clin Oncol 22: 785-94
8. Holoye PY, Jenkins DE, Greenberg SD (1976) Pulmonary toxicity in long-term administration of BCNU. Cancer Treat Rep 60: 1691-4
9. Ingrassia TS 3rd, Ryu JH, Trastek VF, Rosenow EC 3rd (1991) Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 66: 173-8
10. Joerger M, Gunz A, Speich R, Pestalozzi BC (2002) Gemcitabine-related pulmonary toxicity. Swiss Med Wkly 132: 17-20
11. Kawai K, Hinotsu S, Tomobe M, Akaza H (1998) Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity. Jpn J Clin Oncol 28: 546-50
12. Madarnas Y, Webster P, Shorter AM, Bjarnason GA (2000) Irinotecan-associated pulmonary toxicity. Anticancer Drugs 11: 709-13
13. Mahmood T, Mudad R (2002) Pulmonary toxicity secondary to procarbazine. Am J Clin Oncol 25: 187-8
14. Matthews JH (1993) Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy. Lancet 342: 988
15. Parvinen LM, Kilkku P, Makinen E, Liukko P, Gronroos M (1983) Factors affecting the pulmonary toxicity of bleomycin. Acta Radiol Oncol 22: 417-21
16. Rabinowits G, Herchenhorn D, Rabinowits M, Weatge D, Torres W (2003) Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. Anticancer Drugs 14: 665-8
17. Richman SD, Levenson SM, Bunn PA, Flinn GS, Johnston GS, DeVita VT (1975) 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity. Cancer 36: 1966-72
18. Richter J, Hastedt R, Dalton JF, Marshall D, Raymond LW, (1979) Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy. Cancer 43: 1607-12
19. Roychowdhury DF, Cassidy CA, Peterson P, Arning M (2002) A report on serious pulmonary toxicity associated with gemcitabine-based therapy. Invest New Drugs 20: 311-15
20. Rudders RA, Hensley GT (1973) Bleomycin pulmonary toxicity. Chest 63: 627-8
21. Samuels ML, Johnson DE, Holoye PY, Lanzotti VJ (1976) Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy. JAMA 235: 1117-20
22. Saxman SB, Nichols CR, Einhorn LH (1997) Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor. Chest 111: 657-60
23. Senan S, Paul J, Thomson N, Kaye SB (1992) Cigarette smoking is a risk factor for bleomycin-induced pulmonary toxicity. Eur J Cancer 28A: 2084
24. Stoica GS, Greenberg HE, Rossoff LJ (2002) Corticosteroid responsive fludarabine pulmonary toxicity. Am J Clin Oncol 25: 340-1
25. Suratt BT, Lynch DA, Cool CD, Jones RB, Brown KK, (2003) Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids. Bone Marrow Transplant 31: 939-41
26. van Barneveld PW, Sleijfer DT, van der Mark TW et al (1984) Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma. Oncology 41: 4-7
27. Yokose N, Ogata K, Tamura H et al (1998) Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. Br J Cancer 77: 2286-90